Background
==========

Neonatal encephalopathy (NE) in the term or late preterm infant is \"a clinically defined syndrome of disturbed neurologic function in the earliest days of life manifested by difficulty with initiating and maintaining respiration, depression of tone and reflexes, subnormal level of consciousness, and often by seizures\" \[[@B1]\]. NE occurs in an estimated 2--5 per 1000 live term births of which up to one quarter experience moderate or severe cerebral injury \[[@B2]-[@B4]\]. Between 10-40% do not survive and as many as 30% exhibit significant long-term neurodevelopmental disability \[[@B5]\].

Randomized controlled trials (RCTs) demonstrated that hypothermic therapy (HT) may improve neurologic and developmental outcomes and reduce death and disability in term infants with NE \[[@B6]-[@B9]\]. As a result, many practitioners have lost equipoise \[[@B10],[@B11]\]. The National Institute of Child Health and Human Development and the American Academy of Pediatrics Committee on Fetus and Newborn caution that clinicians should follow published trial protocols, ensure systematic follow-up of survivors, and submit patient data to registries when using HT outside of a trial \[[@B12],[@B13]\]. Registries, by documenting the natural history of enrolled patients as they present for care, monitor clinical patterns and patient outcomes in rare disorders such as NE and track the "real world" dissemination of a novel therapy like HT \[[@B14]\].

The Vermont Oxford Network (VON) is a non-profit voluntary collaboration of health care professionals dedicated to improving the quality and safety of medical care for newborn infants and their families at over 850 neonatal intensive care units (NICU) around the world. The VON Neonatal Encephalopathy Registry (NER) was established in 2006.

The primary objective is to characterize infants born with NE, including perinatal and antenatal risk factors, how these infants are identified, the evaluations and treatments they receive, and their outcomes. Secondary objectives include monitoring the dissemination and uptake of the novel therapies such as HT and description of variation of care applied to NE infants. These data will help define clinical research questions and identify opportunities for improved care of NE. This manuscript describes the methods and basic demographic results of the VON NER.

Methods
=======

Hospitals could enroll patients in the NER through participation in one of two databases maintained by VON. The very low birth weight (VLBW) database includes any infant born alive at a participating hospital with a birth weight 401--1500 grams or a gestational age of 22--29 weeks regardless of where the infant receives care, as well as any outborn infant meeting these criteria admitted to any location in the hospital within 28 days of birth without first having gone home. The Expanded database includes any infant regardless of birth weight or gestational age admitted to the hospital's NICU by day 28.

In 2006 and 2007, only VON Expanded database centers could participate in the NER. Beginning in 2008, all VON database participating centers were eligible. Participation in the NER requires no additional fee. VON uses these data for research and reporting, but maintains the confidentiality of individual hospital data. Participating hospitals receive reports comparing their local data with the Registry as a whole. A participating NER center submitted data on one or more eligible infants.

Infant eligibility
------------------

Any infant born at 36 weeks gestation or more displaying evidence of NE within 3 days of birth is eligible. NE is defined as presence of seizures and/or altered consciousness (stupor, coma). In order to cast a wide net that captures all infants potentially affected by NE independent of the adequacy of their neurologic exam, infants with a 5 minute Apgar score of ≤ 3 are included. Accordingly, infants that received neuromuscular blockade are also eligible since their level of conscious could not be assessed. Regardless of neurologic status, any infant that received HT is eligible. Infants born with central nervous system (CNS) birth defects are excluded (Figure [1](#F1){ref-type="fig"}).
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Data items
----------

The VON NER Steering Committee chose data items to characterize the population of all infants with NE, identify potential antecedents, evaluate variations in current practice, and monitor the dissemination of HT and adherence to the RCT efficacy standards. Data items include: patient identifiers, patient selection criteria, infant characteristics, treatments and tests, and outcomes at time of disposition. Where possible, data forms follow standards and terminology derived from existing studies to contribute to evolving medical knowledge. Participating centers receive explicit data definitions for each variable to ensure internal validity and uniform data acquisition. A complete catalogue of data items and definitions are in the manual of operations published on the VON website: <http://www.vtoxford.org/tools/downloads.aspx>.

Centers collect and submit data using freely provided VON eNICQ software, which provides easy to use on-screen data definitions, immediate feedback on issues such as missing or out-of-range values, and error checking for logical inconsistencies. VON staff members perform additional data assessment and contact hospitals about missing data items, unresolved records, out-of-range values, and appropriate modifications as indicated. Only de-identified data are submitted to VON.

The Registry does not dictate patient care, propose any interventions, or endorse any protocols for treatment. Each infant receives care according to the standards of that institution. There is no expected increased risk for participation of individual patients and only de-identified data are submitted. The University of Vermont and State Agricultural College Committee on Human Research in the Medical Sciences (CHRMS) Institutional Review Board (IRB) at the University of Vermont granted ethical approval for the methods of the NER (reference number CHRMS 06--100). Additionally, participating hospitals gained local IRB approval for the participation in the Registry. VON requires documentation of each participating center's local IRB approval before participation in the Registry. Submitted data becomes the property of VON. The Network may use these data for research and reporting, but maintains the confidentiality of individual hospital data.

Outcomes of interest in the NER include death prior to hospital discharge, survivor disposition status, neurologic course, presence of seizures, common neonatal co-morbidities, and adverse events associated with HT including the following: arrhythmia, thrombosis, severe hypotension, seizure during re-warming, scalp edema, skin breakdown, sclerema neonatorum, thrombocytopenia, and infection. These outcomes will be addressed in future NER studies.

Data analysis
-------------

We summarized demographic and clinical characteristics with percentages for categorical variables, mean (and standard deviation) for normally distributed variables, and median (and interquartile range) for other continuous variables. Hospital characteristics come from the VON Annual Survey.

Results
=======

Hospital participation
----------------------

From 2006 to 2010, 95 centers registered infants in the NER (Table [1](#T1){ref-type="table"}). Participating hospitals averaged 686 (Quartile 1 (Q1): 473, Quartile 3 (Q3): 830) annual NICU admissions. A complete list of participating hospitals is presented in Table [2](#T2){ref-type="table"}. We averaged each center's annual volume across all of the years in which the center submitted NER records. The mean number of infants that met eligibility requirements per center was 44.5 (Q1: 15.0, Q3: 57.0).

###### 

Growth of Vermont Oxford Network National Encephalopathy Registry: Participating centers and infants per year, 2006-2010

  **Year of birth**   **Number of centers**   **Number of infants**
  ------------------- ----------------------- -----------------------
  2006                41                      433
  2007                37                      547
  2008                62                      813
  2009                87                      1229
  2010                85                      1210
  2006-2010           95                      4232

###### 

Hospitals registering infants in the Vermont Oxford Network Neonatal Encephalopathy Registry, 2006--2010

  Name                                                 *City*           *State*          *Country*
  ---------------------------------------------------- ---------------- ---------------- ----------------------
  Cork University Maternity Hospital                   Cork                              Ireland
  National Maternity Hospital                          Dublin                            Ireland
  Rotunda Hospital                                     Dublin                            Ireland
  Hospital de S. Joao                                  Porto                             Portugal
  Hospital Sant Joan de Deu                            Barcelona                         Spain
  Latifa Hospital                                      Dubai                             United Arab Emirates
  Southmead Hospital                                   Bristol                           United Kingdom
  Arkansas Children\'s Hospital                        Little Rock      Arkansas         United States
  UC Irvine Medical Center                             Orange           California       United States
  Sharp Mary Birch Hospital for Women                  San Diego        California       United States
  Santa Clara Valley Medical Center                    San Jose         California       United States
  The Children\'s Hospital                             Aurora           Colorado         United States
  Exempla St. Joseph Hospital                          Denver           Colorado         United States
  Poudre Valley Health System                          Fort Collins     Colorado         United States
  Yale New Haven Children\'s Hospital                  New Haven        Connecticut      United States
  Christiana Care Health Services                      Newark           Delaware         United States
  Children\'s Hospital of SW Florida at Lee Memorial   Fort Myers       Florida          United States
  Baptist Children\'s Hospital                         Miami            Florida          United States
  Miami Children\'s Hospital                           Miami            Florida          United States
  St. Joseph\'s Children\'s Hospital of Tampa          Tampa            Florida          United States
  Tampa General Hospital                               Tampa            Florida          United States
  Medical Center at Columbus Regional, The             Columbus         Georgia          United States
  St. Luke\'s Regional Medical Center                  Boise            Idaho            United States
  Evanston Hospital                                    Evanston         Illinois         United States
  Edward Hospital and Health Services                  Naperville       Illinois         United States
  Advocate Lutheran General Hospital                   Park Ridge       Illinois         United States
  Rockford Memorial Hospital                           Rockford         Illinois         United States
  St. John\'s Hospital                                 Springfield      Illinois         United States
  Carle Foundation Hospital                            Urbana           Illinois         United States
  Central DuPage Hospital                              Winfield         Illinois         United States
  St. Luke\'s Hospital                                 Cedar Rapids     Iowa             United States
  Blank Children\'s Hospital                           Des Moines       Iowa             United States
  Overland Park Regional Medical Staff                 Overland Park    Kansas           United States
  Wesley Medical Center                                Wichita          Kansas           United States
  Kosair Children\'s Hospital                          Louisville       Kentucky         United States
  Woman\'s Hospital                                    Baton Rouge      Louisiana        United States
  Eastern Maine Medical Center                         Bangor           Maine            United States
  Barbara Bush Children\'s at Maine Medical            Portland         Maine            United States
  University of Maryland Division of Neonatology       Baltimore        Maryland         United States
  Frederick Memorial Hospital                          Frederick        Maryland         United States
  Massachusetts General Hospital for Children          Boston           Massachusetts    United States
  UMass Memorial Healthcare                            Worcester        Massachusetts    United States
  U. of MI, CS Mott Children\'s, Brandon NICU          Ann Arbor        Michigan         United States
  Henry Ford Hospital                                  Detroit          Michigan         United States
  DeVos Children\'s, Spectrum Health                   Grand Rapids     Michigan         United States
  Sparrow Hospital                                     Lansing          Michigan         United States
  University of MN Children\'s Hospital, Fairview      Minneapolis      Minnesota        United States
  North Memorial Medical Center                        Robbinsdale      Minnesota        United States
  St. Cloud Hospital                                   Saint Cloud      Minnesota        United States
  St. Francis Medical Center, Cape Girardeau           Cape Girardeau   Missouri         United States
  Cardinal Glennon Children\'s Hospital                St. Louis        Missouri         United States
  St. Louis Children\'s Hospital                       St. Louis        Missouri         United States
  St. Elizabeth Regional Medical Center                Lincoln          Nebraska         United States
  Alegent Health Bergen Mercy Medical Center           Omaha            Nebraska         United States
  Nebraska Medical Center                              Omaha            Nebraska         United States
  Albany Medical Center                                Albany           New York         United States
  Weiler Hospital Montefiore                           Bronx            New York         United States
  Winthrop University Hospital                         Mineola          New York         United States
  Columbia University Medical Center                   New York         New York         United States
  Golisano Children\'s Hospital at Strong              Rochester        New York         United States
  Mission Children\'s Hospital                         Asheville        North Carolina   United States
  Duke University                                      Durham           North Carolina   United States
  Cape Fear Valley Medical Center                      Fayetteville     North Carolina   United States
  Women\'s Hospital of Greensboro                      Greensboro       North Carolina   United States
  Pitt County Memorial Hospital                        Greenville       North Carolina   United States
  WAKEMED Faculty Physicians, Wake Medical Center      Raleigh          North Carolina   United States
  Brenner Children\'s Hospital at WFUBMC               Winston-Salem    North Carolina   United States
  Akron Children\'s Hospital                           Akron            Ohio             United States
  Children\'s Hospital Medical Center Cincinnati       Cincinnati       Ohio             United States
  Henry Zarrow Neonatal Intensive Care Unit            Tulsa            Oklahoma         United States
  Rogue Valley Medical Center                          Medford          Oregon           United States
  Providence St. Vincent Medical Center                Portland         Oregon           United States
  Randall Children\'s Hospital at Legacy Emanuel       Portland         Oregon           United States
  Salem Hospital                                       Salem            Oregon           United States
  Sacred Heart Medical Center                          Springfield      Oregon           United States
  St. Luke\'s University Hospital                      Bethlehem        Pennsylvania     United States
  Geisinger Medical Center                             Danville         Pennsylvania     United States
  Penn State Children\'s Hospital                      Hershey          Pennsylvania     United States
  Thomas Jefferson University Hospital                 Philadelphia     Pennsylvania     United States
  Magee Women\'s Hospital                              Pittsburgh       Pennsylvania     United States
  Palmetto Health Richland                             Columbia         South Carolina   United States
  Children\'s Hospital of Greenville                   Greenville       South Carolina   United States
  University of Tennessee Medical Center               Knoxville        Tennessee        United States
  Baptist Memorial Hospital for Women                  Memphis          Tennessee        United States
  Monroe Carell Jr. Children\'s Hospital Vanderbilt    Nashville        Tennessee        United States
  Cook Children\'s Medical Center                      Fort Worth       Texas            United States
  Christus Santa Rosa Healthcare                       San Antonio      Texas            United States
  Methodist Children\'s Hospital                       San Antonio      Texas            United States
  Vermont Children\'s at Fletcher Allen Health Care    Burlington       Vermont          United States
  Carilion Clinic Children\'s Hospital                 Roanoke          Virginia         United States
  Swedish Medical Center                               Seattle          Washington       United States
  West Virginia University School of Medicine          Morgantown       West Virginia    United States
  Gundersen Lutheran Medical Center                    LaCrosse         Wisconsin        United States
  St. Mary\'s Hospital Medical Center                  Madison          Wisconsin        United States
  Wheaton Franciscan Healthcare at St. Joseph          Milwaukee        Wisconsin        United States

Almost all (97%) NER centers were non-profit (Table [3](#T3){ref-type="table"}). Minority-serving hospitals, those that treat \>35% black infants, \[[@B15]\] constituted 18% of the participating hospitals. Over three-fourths of the participating centers had pediatric residents or neonatology fellows working within their NICUs. Almost all centers had MRI scanning capability.

###### 

Hospital Characteristics in Vermont Oxford Network Neonatal Encephalopathy Registry

  **Characteristic\***        **Number of hospitals**   **%**
  --------------------------- ------------------------- -------
  Non-profit                  92                        96.8
  Minority Serving Hospital   17                        17.9
  Teaching Hospital           72                        75.8
  Children's Hospital         15                        15.8
  MRI Scanning Capability     92                        96.8
  AAP Level IIIA              9                         9.5
  AAP Level IIIB              49                        51.6
  AAP Level IIIC and IIID     33                        34.7
  AAP Level Unknown           4                         4.2

\*Based on the last year in which the center submitted NER data.

VON classifies participating NICUs using a method based on the AAP Levels of Neonatal Care classification set forth by the Committee on Fetus and Newborn \[[@B16]\]. The VON annual survey does not differentiate between Level IIIC (those that provide major surgical services excluding serious congenital heart anomalies that require cardiopulmonary bypass or extracorporeal membrane oxygenation (ECMO)) and Level IIID hospitals (those that do provide major surgery including surgical repair of serious congenital heart anomalies or ECMO). All NER hospitals classified themselves in the annual survey as subspecialty intensive care (level III) hospitals. The majority (52%) were level IIIB hospitals, which have no restrictions on the duration of mechanical ventilation but do not provide major surgery.

Infant eligibility
------------------

Of the 4232 eligible infants, 59% suffered a clinically apparent seizure within the first 72 hours of life, 50% had a 5 minute Apgar score of 3 or less, 38% had HT, 18% had stupor/coma, and 2% had neuromuscular blockade. HT as the sole eligibility criteria accounted for 8% of the entire sample. Many infants (39%) experienced more than one eligibility criterion. Among infants with multiple eligibility criteria, 30.7% received hypothermia, 28.1% had an Apgar score of 3 or less, 26.9% had a clinically apparent seizure, 17.2% had stupor or coma, and only 1.2% had neuromuscular blockade.

Infant characteristics
----------------------

Registered infants had a median birth weight of 3298 grams (Q1: 2905, Q3: 3685) and a median gestational age of 39 weeks (Q1: 38, Q3: 40). Over one-third of infants were not admitted to the NICU until 6 hours after birth (Table [4](#T4){ref-type="table"}). Of those not admitted until after 6 hours, 81% were outborn. Sixteen percent were small for gestational age. Over 60% of infants required transport. Over half (56%) were delivered by cesarean section (C/S), the majority of which had a trial of labor before the C/S. Fourteen percent of infants had a traumatic birth injury. A cord gas was obtained at the time of delivery in 53% of enrolled infants. Of those obtained, the mean pH was 7.0 (Q1: 6.9, Q3: 7.2) and the mean cord gas base excess was −12.2 (Q1: -17.6, Q3: -6.0).

###### 

Characteristics of Infants in Vermont Oxford Network National Encephalopathy Registry, 2006-2010

                                           **Eligible**   **N**   **%**
  ---------------------------------------- -------------- ------- -------
  Admission Time \> 6hrs                   4165           1395    33.5
  Small for Gestational Age                4231           676     16.0
  Inborn                                   4232           1682    39.7
  Maternal Race                            4194                    
   Asian                                                  95      2.3
   Black                                                  777     18.5
   Hispanic                                               574     13.7
   White                                                  2675    63.8
   Other                                                  73      1.7
  Number of Births                         4232                    
   Singleton                                              4167    98.5
   Twins                                                  65      1.5
  Delivery Method                          4228                    
   Spontaneous vaginal                                    1414    33.4
   Vaginal delivery using vacuum/forceps                  450     10.6
   Cesarean section before labor                          840     19.9
   Cesarean section after labor                           1524    36.1
  Traumatic Birth Injury                   4206           590     14.0
  Meconium Aspiration Syndrome             4227           515     12.2
  Cord Gas Obtained\*                      3699           1946    52.6

\*The NER specified arterial cord blood gas from 2006--2008 but in 2009--2010 included umbilical cord blood from any source.

Evaluations and treatments
--------------------------

Of NER infants, 64% received ventilator support, 38% received HT, and 65% received anticonvulsants for any indication (Table [5](#T5){ref-type="table"}). Thirteen percent received inhaled nitric oxide and 3% received ECMO. Approximately 9% of the infants had surgery during their hospitalization, mainly abdominal. Sixty-six percent of infants underwent a head MRI and 49% received a cranial ultrasound. Sixty-seven percent had a full channel encephalogram (EEG) while 33% underwent amplitude integrated EEG monitoring. Overall, 36% of infants did not have a blood gas obtained from any site (arterial, venous, or capillary). Of those infants with a value, the worst gas results yielded a mean pH of 7.1 (Q1: 7.0, Q3: 7.3) and a mean base excess of −13.0 (Q1: -20.0, Q3: -6.0).

###### 

Evaluations and treatments received by infants in the Vermont Oxford Network National Encephalopathy Registry, 2006-2010

                                                  **Elig**   **N**   **%**
  ----------------------------------------------- ---------- ------- -------
  Therapeutic hypothermia                         4232       1626    38.4
  Anticonvulsant during hospital course           4177       2715    65.0
  Blood gas obtained within 24 hours^1^           1723       1083    62.9
  Blood gas obtained within first hour^2^         2281       1462    64.1
  Cranial ultrasound                              4172       2045    49.0
  Cranial CT                                      4168       951     22.8
  MRI                                             4170       2742    65.8
  Full channel EEG                                4171       2777    66.6
  Amplitude integrated EEG (aEEG)                 4168       1376    33.0
  High flow nasal cannula (HFNC)                  4167       1371    32.9
  Nasal CPAP                                      4168       748     18.0
  Ventilator                                      4168       2723    65.3
  High frequency oscillatory ventilation (HFOV)   4168       486     11.7
  Extracorporeal membrane oxygenation (ECMO)      4167       118     2.8
  Inhaled nitrous oxide (iNO)                     4167       556     13.3
  Any Surgery                                     4168       379     9.0
   Cardiac                                        4168       22      0.5
   PDA                                            4168       9       0.2
   Abdominal                                      4168       301     7.2
   CNS                                            4168       25      0.6

^1^Question for 2006--2008.

^2^Question for 2009--2010.

Outcomes
--------

Of all infants, 87% survived (Table [6](#T6){ref-type="table"}). Among the survivors, at discharge 38% were on anticonvulsants, 86% received all feeds by mouth, 6% had home monitoring, and 1% had ventilator support. The typical length of stay among surviving infants discharged to home was 11 days (Q1: 7, Q3: 19). Of infants that died during their initial hospitalization, the median day of death was day 4 (Q1: 2, Q3: 9).

###### 

Outcomes at initial disposition of all infants in the Vermont Oxford Network National Encephalopathy Registry, 2006-2010

                                 **Elig**   **N**   **%**
  ------------------------------ ---------- ------- -------
  Survival status                                    
   Died                          4232       551     13.0
   Alive                         4232       3676    86.9
   Unknown                       4232       5       0.1
  **Among Survivors**                                
  Anticonvulsants at discharge   3670       1393    38.0
  Feeds at discharge                                 
   Enteral, all by mouth         3670       3141    85.6
   Enteral, none by mouth        3670       259     7.1
   Some by mouth                 3670       201     5.5
   No enteral feeding            3670       69      1.9
  Hearing screen passed          3212       2942    91.6
  Discharged home                                    
   On monitor                    3439       220     6.4
   On oxygen                     3441       132     3.8
   On ventilator                 3676       50      1.4

Discussion
==========

A patient registry is an organized system that uses observational study methods to collect uniform data and evaluate specified outcomes for a population defined by a particular disease, condition, or exposure, and that serves a predetermined scientific, clinical, or policy purpose(s) \[[@B17]\]. Registries can support clinical conditions, health care services, or products, and can address questions ranging from treatment effectiveness and safety to the quality of care delivered.

The VON NER captures data and characterizes infants with NE and a subset treated with HT. To increase external validity, inclusion criteria for the VON NER are intentionally few and simple: the presence of seizures and/or altered consciousness (stupor, coma) during the first 72 hours of life. Additional inclusion parameters capture all potentially encephalopathic infants treated with hypothermia independent of their neurologic status and infants whose neurologic status might be difficult to assess (e.g., paralyzed, mechanically ventilated, or sedated infants).

Historically, the presence of NE has been considered *sine qua non* of hypoxic-ischemic injury or birth asphyxia. However, the etiology of NE is not limited to hypoxic-ischemic injury and displays considerable diversity \[[@B18]\]. Only a small proportion of infants in the NER had documented exposure to acute intrapartum asphyxia ("sentinel events"). These findings reflect previous research suggesting that a minority (25-35%) of cases of NE attributed to birth asphyxia have a clear contributing sentinel event in the intrapartum period \[[@B13],[@B19]\]. The VON NER is being used describe the frequency with which recognized antecedents of NE occurred in a large sample of encephalopathic term newborns. These findings will have implications for future studies of the etiology of NE.

Timely recognition of NE infants affected by HIE is crucial to the success of HT. Very few infants in the Registry were identified as having altered consciousness on neurologic exam. In fact, the most common route for entry was following a seizure. Among the subset of NE infants caused by HIE, by the time an infant suffers seizures it may be too late to achieve the full benefit of HT \[[@B20],[@B21]\]. Given that birth asphyxia is often presumed the etiology of NE, it is striking to note that umbilical cord blood gas examinations were obtained in just over half of the infants during their perinatal courses. Similarly, less than 40% of the infants had blood gas sampling performed following birth. Since neurologic exams and umbilical and cord blood gas examinations are commonly used tests to determine whether or not HT is appropriate, these data suggest there is room for improvement in the recognition and evaluation of NE.

Nearly four in ten (38%) NER infants were eligible due to exposure to HT. However the majority were also encephalopathic and in only a small percentage (8%) was HT the sole criteria for eligibility. One third of infants receiving HT were admitted after 6 hours of life when any neuroprotective benefit from HT may be diminished. Over 60% of NE infants required transport, which may be a significant contributing factor in the observed delay in admission. Identification of gaps between the conditions for implementation of HT in clinical trials and in what is observed in clinical practice and identification of areas of improvement are focused areas of ongoing NER research.

The optimal routine evaluation and treatments of infants with NE is unknown. The majority of infants were treated with anticonvulsants but significant variation was noted in the approach to electroencephalographic monitoring. Only 66% had optimal imaging (head MRI) and 23% underwent a suboptimal exam (head CT) according to accepted quality standards \[[@B22]\]. Ongoing work of the NER will identify and document variation in the evaluations and medical treatments these infants receive, providing valuable information for future RCTs.

Variation in patient selection and adherence to established protocols contributes to differences in survival, adverse events, and long-term outcomes for treated infants \[[@B23],[@B24]\]. Among infants in the NER, 13% died, a proportion similar to the mortality rate of NE observed in a population based report by Badawi et al. (9%) despite different inclusion criteria \[[@B3]\]. Of infants that survived to discharge, a significant proportion required ventilation, monitoring, and other medical care at home. These findings are consistent with previous observations of the medical burden and mortality associated with NE infants and underscores the need for improvement of the quality of care. The NER provides benchmarking data that member centers use while participating in VON multicenter quality improvement collaborations.

A large proportion of cerebral palsy, cognitive disability, and epilepsy arise in infants born at term or late preterm \[[@B25]\]. In contrast to preterm infant births, the births of term and late preterm infants are scattered over a broad range of facilities, many of which care for relatively few infants each year with NE. NER hospitals may be the best representation of those caring for encephalopathic infants in the "real world" and represent a generalizable view of HT as it occurs outside the academic sector or in a research setting. VON NER centers are heterogeneous in terms of size and numbers of infant records submitted. However, the participating nurseries were largely non-profit tertiary referral centers. Slightly more than half were teaching hospitals.

The UK TOBY Cooling Register also captures data on neonatal HT \[[@B26],[@B27]\]. The TOBY Register started after the TOBY trial of HT closed enrollment, upon recognition that many physicians were offering HT out of the context of any trial \[[@B6],[@B28]\]. It is a phase 4 study of the specific methods of the trial, with a narrower set of inclusion criteria than the VON NER. Comparison of information in the VON and the TOBY registries will be useful in understanding dissemination of HT when implemented strictly in accordance with a previous trial (TOBY) versus in a more broad clinical setting (VON NER).

Limitations
-----------

Registries have important limitations with respect to RCTs. RCTs have strong internal validity, but often are focused on a relatively homogeneous group of patients from whom significant numbers are excluded at the cost of external validity or widespread generalizability. Registries aim for greater generalizability with populations relevant to all clinical settings. The nature of registry data limits clinicians from applying registry data to clinical decision-making. However, careful data collection and analyses of the NER, with oversight by the Steering Committee, aim to limit the potential for bias and misinterpretation of data. Awareness and recognition of bias in registry data adds to its heuristic value for planning clinical research or guiding NICU policies.

Conclusion
==========

A registry is well suited to the study of the heterogeneous population of NE infants and to the characterization of how interventions such as HT are implemented in clinical practice. This manuscript describes the methods and initial demographic results of the VON NER. Future manuscripts are planned on antecedents of NE, evaluation and treatment of neonatal seizure, optimal neuroimaging of NE infants, and hypothermia for HIE in routine practice.
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